In response to notable increases in tick-associated illnesses in the United States, recent public health policies encouraged multi-sector collaborative approaches to preventing vector-borne diseases. Primary prevention strategies focus on educating the public about risks for tick-borne diseases and encouraging adoption of personal protection strategies. Accurate descriptions of when and where people are at risk for tick-borne diseases aid in the optimization of prevention messaging.
View Article and Find Full Text PDFBackground: Limited treatment options exist for inoperable thyroid cancers. We evaluated whether neoadjuvant use of systemic tyrosine kinase inhibitors facilitates surgery of differentiated thyroid cancers in this challenging context.
Methods: A single-institution experience of 42 patients receiving tyrosine kinase inhibitors for papillary, follicular and anaplastic thyroid carcinomas between 2018 and 2023 was reviewed to identify differentiated thyroid cancers treated with neoadjuvant tyrosine kinase inhibitors (dabrafenib/trametinib, lenvatinib/pembrolizumab, or lenvatinib alone) via multidisciplinary protocols.
We report the genomic sequence of the hard tick relapsing fever spirochete strain MN18-0001. causes human illness and is geographically widespread in spp. (Acari: Ixodidae) ticks.
View Article and Find Full Text PDFBackground: Bartonella spp. infect a variety of vertebrates throughout the world, with generally high prevalence. Several Bartonella spp.
View Article and Find Full Text PDF